Polish Agency Awarded Grant for Annamycin Clinical Trial for STS
TBIT / Pixabay

Polish Agency Awarded Grant for Annamycin Clinical Trial for STS

In a recent press release, pharmaceutical company Moleculin Biotech, Inc. ("Moleculin") shared a recent advance in the sphere of medical and health research. Agencja Badań Medycznych, a Polish agency which contributes…

Continue Reading Polish Agency Awarded Grant for Annamycin Clinical Trial for STS

Study of the Week: New Genetic Predisposition Variants in Rhabdomyosarcoma

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: New Genetic Predisposition Variants in Rhabdomyosarcoma
Data Ownership as Leverage in Accelerating Rare Disease Drug Development
source: pixabay.com

Data Ownership as Leverage in Accelerating Rare Disease Drug Development

Patient groups can optimize patient registries, cross-sectional studies, and/or longitudinal natural history studies to maximize collaborations with sponsors of orphan drugs and gene therapies. Written by Harsha Rajasimha, MS, PhD…

Continue Reading Data Ownership as Leverage in Accelerating Rare Disease Drug Development